Stay updated with breaking news from Valency Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
15.04.2022 - Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced that its Annual Report for 2021 is now available on the Company’s corporate ...
Immunicum AB ("Immunicum" publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced that the company will participate
Investegate announcements from Immunicum AB, Immunicum AB: Immunicum to Participate in the New Cancer Research Consortium Oncode-PACT
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established...
08.04.2022 - Press Release Stockholm, Sweden, April 8, 2022 NOTICE OF ANNUAL GENERAL MEETING IN IMMUNICUM AB (PUBL) The shareholders of Immunicum AB (publ) (the “Company”), reg. no 556629-1786, are hereby invited to the Annual General ...